{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:10:13Z","timestamp":1791231013124,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jpba.2016.09.045","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T11:02:17Z","timestamp":1475319737000},"page":"207-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Selective functional activity measurement of a PEGylated protein with a modification-dependent activity assay"],"prefix":"10.1016","volume":"132","author":[{"given":"Alfred","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Engelmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Haindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Turecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.09.045_bib0005","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V92.11.3983","article-title":"The life cycle of coagulation factor VIII in view of its structure and function","volume":"92","author":"Lenting","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2016.09.045_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2003-37935","article-title":"Structure and function of the factor VIII gene and protein","volume":"29","author":"Thompson","year":"2003","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jpba.2016.09.045_bib0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/312337a0","article-title":"Structure of human factor VIII","volume":"312","author":"Vehar","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2016.09.045_bib0020","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/elps.201000627","article-title":"Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE","volume":"32","author":"Monetti","year":"2011","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2016.09.045_bib0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","article-title":"Chemistry for peptide and protein PEGylation","volume":"54","author":"Roberts","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2016.09.045_bib0030","first-page":"45","article-title":"Conjugates of peptides and proteins to PEG","volume":"283","author":"Morpurgo","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2016.09.045_bib0035","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2004-11-4230","article-title":"LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo","volume":"106","author":"Bovenschen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2016.09.045_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-3659(02)00042-1","article-title":"Polyethyleneglycole conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties","volume":"80","author":"Holtsberg","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2016.09.045_bib0045","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1517\/13543784.15.7.815","article-title":"Pegylated arginine deiminase: a novel anticancer agent","volume":"15","author":"Feun","year":"2006","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.jpba.2016.09.045_bib0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/bc000082g","article-title":"Rational design of a potent, long-lasting form of interferon: a 40kDa branched polyethylene glycol-conjugated Interferon alpha-2\u03b1 for the treatment of hepatitis C","volume":"12","author":"Bailon","year":"2001","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.jpba.2016.09.045_bib0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0169-409X(02)00026-1","article-title":"PEGylated antibodies and antibody fragments for improved therapy: a review","volume":"54","author":"Chapman","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2016.09.045_bib0060","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jpba.2008.09.027","article-title":"Quantitation of free polyethylene glycol in PEGylated protein conjugate by size exclusion HPLC with refractive index (RI) detection","volume":"48","author":"Li","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2016.09.045_bib0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/abio.1996.0233","article-title":"A colorimetric assay for estimation of polyethylen glycole and polyethylen glycolated proteins using ammonium ferrothiocyanate","volume":"237","author":"Nag","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2016.09.045_bib0070","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/rcm.1175","article-title":"Optimization of the PEGylation process of a peptide by monitoring with matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"17","author":"Na","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2016.09.045_bib0075","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jms.1746","article-title":"MALDI linear TOF mass spectrometry of PEGylated (glyco)proteins","volume":"45","author":"Seyfried","year":"2010","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2016.09.045_bib0080","unstructured":"A. Weber, A. Engelmaier, H.P. Schwarz, Modification-dependent activity assay US Patent 8 785 139 B4 2014."},{"key":"10.1016\/j.jpba.2016.09.045_bib0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2144\/01302rr03","article-title":"Sensitive measurement of polyethylen glycole modified proteins","volume":"30","author":"Tsai","year":"2001","journal-title":"Biotechniques"},{"key":"10.1016\/j.jpba.2016.09.045_bib0090","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/bc050133f","article-title":"Monoclonal antibody-based quantitation of poly(ethylen glycole)-derivatized proteins, liposomes and nanoparticles","volume":"16","author":"Cheng","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpba.2016.09.045_bib0095","unstructured":"http:\/\/www.epitomics.com\/pdf\/anti_PEG_v2. downloaded pdf January 8, 2015."},{"key":"10.1016\/j.jpba.2016.09.045_bib0100","unstructured":"European Medicines Agency Guideline on bioanalytical method validation, issued July 2011. EMEA\/CHMP\/EWP\/192217\/2009."},{"key":"10.1016\/j.jpba.2016.09.045_bib0105","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1055\/s-0037-1619772","article-title":"BAX 855, a PEGylated rFVIII product with prolonged half-life","volume":"32","author":"Turecek","year":"2012","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.jpba.2016.09.045_bib0110","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2015-03-630897","article-title":"Pegylated full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A","volume":"126","author":"Konkle","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2016.09.045_bib0115","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1021\/bc200478w","article-title":"Analytical measurement of PEGylated molecules","volume":"23","author":"Cheng","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpba.2016.09.045_bib0120","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/acs.bioconjchem.5b00442","article-title":"Development, validation, and application of a novel ligand-binding assay to selectively measure PEGylated recombinant human coagulation factor VIII (BAX 855)","volume":"26","author":"Weber","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpba.2016.09.045_bib0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(88)90567-3","article-title":"The molecular basis of blood coagulation","volume":"53","author":"Furie","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jpba.2016.09.045_bib0130","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1021\/ac1009832","article-title":"Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography\/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma","volume":"82","author":"Xu","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2016.09.045_bib0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1385\/1-59259-076-4:373","article-title":"How to set up an ELISA","volume":"40","author":"Jordan","year":"2000","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.jpba.2016.09.045_bib0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000233512","article-title":"Polyethylen glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylen glycol modified allergens or placebo and in healthy blood donors","volume":"74","author":"Richter","year":"1984","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.jpba.2016.09.045_bib0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0305-4179(82)90136-X","article-title":"Polyethylene glycol intoxication in burn patients","volume":"9","author":"Bruns","year":"1982","journal-title":"Burns Incl. Therm. Inj."},{"key":"10.1016\/j.jpba.2016.09.045_bib0150","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/jcm.32.10.2441-2447.1994","article-title":"Determination of parallelism and nonparallelism in bioassay dilution curves","volume":"32","author":"Plikaytis","year":"1994","journal-title":"J. Clin. Microbiol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516307488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516307488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:53:54Z","timestamp":1760000034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708516307488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":30,"alternative-id":["S0731708516307488"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.09.045","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective functional activity measurement of a PEGylated protein with a modification-dependent activity assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}